BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 29401143)

  • 1. False-Positive 18F-FDG PET/CT Due to Filgrastim That Induced Extramedullary Liver Hematopoiesis in a Burkitt Lymphoma.
    Maffione AM; Rampin L; Rossella P; Pecori S; Colletti PM; Rubello D
    Clin Nucl Med; 2018 Apr; 43(4):e130-e131. PubMed ID: 29401143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low rate of spleen involvement in sporadic Burkitt lymphoma at staging on PET-CT.
    Davidson T; Priel E; Schiby G; Raskin S; Chikman B; Nissan E; Benjamini O; Nissan J; Goshen E; Ben-Haim S; Salomon O; Avigdor A
    Abdom Radiol (NY); 2018 Sep; 43(9):2369-2374. PubMed ID: 29460043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 18F-FDG PET/CT Imaging of Burkitt Lymphoma Presenting With Unusual Muscle Involvement.
    Dirlik Serim B; Gurleyen Eren T; Oz Puyan F; Durmus Altun G
    Clin Nucl Med; 2016 Aug; 41(8):643-5. PubMed ID: 27124681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT in Extranodal Burkitt Lymphoma.
    Jiménez Granero P; García Gómez FJ; Ruiz Mercado M; Borrego Dorado I
    Clin Nucl Med; 2015 Sep; 40(9):748-9. PubMed ID: 26098290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkitt lymphoma and cavernous sinus syndrome with breast uptake on 18F-FDG-PET/CT: A case report.
    Reyneke F; Mokgoro N; Vorster M; Sathekge M
    Medicine (Baltimore); 2017 Nov; 96(46):e8687. PubMed ID: 29145302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma.
    Carrillo-Cruz E; Marín-Oyaga VA; Solé Rodríguez M; Borrego-Dorado I; de la Cruz Vicente F; Quiroga Cantero E; Manzanares Pérez M; Capote FJ; Ramírez Sánchez MJ; Espigado Tocino I; Pérez-Vega H; Vázquez-Albertino R; Pérez-Simón JA
    Eur J Haematol; 2015 Jan; 94(1):23-30. PubMed ID: 24520874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lenograstim-Induced Nodal Extramedullary Hematopoiesis: A Challenging Diagnosis in Lymphoma Evaluation With 18F-FDG PET/CT.
    Leroy-Freschini B; Nicolae A; Iltis-Roux A
    Clin Nucl Med; 2020 Aug; 45(8):e373-e375. PubMed ID: 32558708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethmoidal and extranodal Burkitt lymphoma in a child with bilateral kidney Burkitt lymphoma lesions incidentally detected by
    Bonacina M; Bertoli M; Albano D; Bertagna F; Laffranchi F; Giubbini R
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):384-386. PubMed ID: 29636232
    [No Abstract]   [Full Text] [Related]  

  • 9. Spectrum of FDG PET/CT findings in Burkitt lymphoma.
    Zeng W; Lechowicz MJ; Winton E; Cho SM; Galt JR; Halkar R
    Clin Nucl Med; 2009 Jun; 34(6):355-8. PubMed ID: 19487844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of Pretherapeutic
    Ding CY; Liu HY; Guo Z; Li TN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):438-443. PubMed ID: 28446289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burkitt Lymphoma/Leukemia Presented on 68Ga-Pentixafor and 18F-FDG PET/CT.
    Chen Z; Xue Q; Huang C; Yao S; Miao W
    Clin Nucl Med; 2022 Jan; 47(1):98-100. PubMed ID: 34115701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt's lymphoma.
    Riad R; Omar W; Sidhom I; Zamzam M; Zaky I; Hafez M; Abdel-Dayem HM
    Nucl Med Commun; 2010 Mar; 31(3):232-8. PubMed ID: 20032800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 18F-FDG PET/CT metabolic activity assessment in infective and neoplastic diseases: a patient with systemic hydatidosis and concomitant Burkitt lymphoma.
    Niccoli Asabella A; Altini C; Pisani AR; Ingravallo G; Rubini G
    Clin Nucl Med; 2013 Jul; 38(7):546-9. PubMed ID: 23640218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubercular Meningitis on 18F-FDG PET/CT: Incidentally Detected and Masquerading as Relapse in a Patient With Ovarian Burkitt Lymphoma.
    Sharma P; Marangmei C
    Clin Nucl Med; 2015 Jul; 40(7):606-7. PubMed ID: 25706796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET and PET/CT in Burkitt's lymphoma.
    Karantanis D; Durski JM; Lowe VJ; Nathan MA; Mullan BP; Georgiou E; Johnston PB; Wiseman GA
    Eur J Radiol; 2010 Jul; 75(1):e68-73. PubMed ID: 19716248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in AIDS-related Burkitt lymphoma.
    Just PA; Fieschi C; Baillet G; Galicier L; Oksenhendler E; Moretti JL
    AIDS Patient Care STDS; 2008 Sep; 22(9):695-700. PubMed ID: 18793085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory Burkitt Lymphoma With False-positive and False-negative Mass Detected on Positron Emission Tomography-computed Tomography After Chemotherapy.
    Shima H; Takaki T; Ito J; Iwabuchi Y; Nakazawa A; Shimada H
    J Pediatr Hematol Oncol; 2023 Oct; 45(7):e915-e916. PubMed ID: 37526341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt's lymphoma.
    Wei WX; Huang JJ; Li WY; Zhang X; Xia Y; Jiang WQ; Fan W; Li ZM
    Chin J Cancer; 2015 Dec; 34(12):608-13. PubMed ID: 26630874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Staging of Burkitt's lymphoma and response to treatment monitored by PET scanning.
    Barrington SF; Carr R
    Clin Oncol (R Coll Radiol); 1995; 7(5):334-5. PubMed ID: 8580066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas.
    Wu HB; Wang QS; Wang MF; Li HS; Zhou WL; Ye XH; Wang QY
    Nucl Med Commun; 2010 Mar; 31(3):195-200. PubMed ID: 20009963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.